Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity representing about 5% of all HL cases. Pathobiology and clinical course differ from classical HL (cHL). This chapter describes the pathologic and clinical characteristics, differential diagnoses, risk factors, and treatment options of NLPHL.
CITATION STYLE
Eichenauer, D. A., & Advani, R. H. (2020). Nodular lymphocyte-predominant hodgkin lymphoma. In Hematologic Malignancies (pp. 317–324). Springer. https://doi.org/10.1007/978-3-030-32482-7_17
Mendeley helps you to discover research relevant for your work.